✓ Last verified: March 25, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: The largest multi-location Spravato network in the Milwaukee metro — 7 clinics across Milwaukee, Oak Creek, Elm Grove, Mequon, Dousman, and Elkhorn make it the most geographically accessible option for treatment-resistant depression patients in southeastern Wisconsin.
| Review Scores | Largest Spravato network in the Milwaukee metro with 7 locations across southeastern Wisconsin |
| Location | Milwaukee, WI |
| Address | 10424 W Bluemound Road, Milwaukee, WI 53226 |
| Phone | (414) 774-1794 |
| Website | americanbehavioralclinics.com |
| Treatments | Spravato (Esketamine) Nasal Spray, IV Ketamine Infusion, Psychiatric Services |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder with Suicidal Ideation |
| Cost | Contact for pricing; insurance accepted |
| Insurance | Most major insurance plans accepted |
| Clinical Lead | Multi-clinician psychiatric team across 7+ Milwaukee-area locations |
HealingMaps Take: American Behavioral Clinics’ multi-location model fundamentally solves an access problem in interventional psychiatry: geographic inconvenience. With 7 Milwaukee-area clinics — Bluemound (flagship at 10424 W Bluemound Rd), Oak Creek, Elm Grove, Layton, Mequon, Dousman (Lake Country), and Elkhorn — a patient anywhere in the southeastern Wisconsin region can find Spravato treatment within a reasonable drive. That matters because Spravato requires twice-weekly visits during induction (4 weeks) followed by weekly or maintenance sessions, and that recurring schedule is logistically difficult if the clinic is far away. The Bluemound location in western Milwaukee serves as the flagship and is easily accessible from I-94. Offering both Spravato AND IV ketamine under the same organizational umbrella means patients have modality flexibility without switching practices. Insurance acceptance across most major plans makes treatment financially realistic for working patients. The multi-location operational sophistication also tends to yield smoother REMS compliance, insurance navigation, and scheduling than single-location clinics. For Milwaukee metro patients who want Spravato delivered with maximum geographic flexibility and insurance coverage, ABC’s network is the default answer.
Market Position: American Behavioral Clinics is a Spravato-certified clinic in the Milwaukee metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. American Behavioral Clinics has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 3-question summary is matched to the protocols and conditions American Behavioral Clinics treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
American Behavioral Clinics offers Spravato and IV ketamine — a 2-protocol practice. Patients can switch between or combine modalities without changing providers. Confirm specific dosing schedules and which protocols are recommended for your condition during your consult.
Yes — American Behavioral Clinics offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
American Behavioral Clinics treats depression via Spravato (FDA-approved for TRD), and IV ketamine (off-label, evidence-based). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Leave a Reply